Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting, 18864-18865 [2016-07321]

Download as PDF 18864 Federal Register / Vol. 81, No. 63 / Friday, April 1, 2016 / Notices FOAs beginning in FY 2017. The application will provide project plans and budgets for upcoming years. This information will permit federal staff to assess whether the proposed activities align with statutory and programmatic requirements and objectives and will result in the implementation of a highquality project. Applications in response to annual FOAs are submitted via Grants.gov. Failure to collect this information would result in the inability of HRSA to collect information necessary for the determination of the responsiveness and quality of applications and would subject the government to undue risk in awarding formula funds under the Federal Home Visiting Program. Applicants will be required to submit several types of information in addition to the SF–424 Forms which are included under a separate Information Collection Request. These types of information include: (1) Project Abstract, (2) Project Narrative, (3) Budget Justification, (4) ProgramSpecific Forms and Tables, and (5) Attachments. Likely Respondents: Eligible entities under the Social Security Act, Title V, Section 511(c) (42 U.S.C., Section 711(c)), as added by Section 2951 of the ACA (Pub. L. 111–148). Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information Number of respondents Form name Number of responses per respondent requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this Information Collection Request are summarized in the table below. Total Estimated Annualized burden hours: Total responses Average burden per response (in hours) Total burden hours Federal Home Visiting Program Formula Funding Opportunity Announcement ........................................................ 56 1 56 80 4,480 Total .............................................................................. 56 1 56 80 4,480 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2016–07319 Filed 3–31–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration asabaliauskas on DSK3SPTVN1PROD with NOTICES Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463, codified at 5 U.S.C. App.), notice is hereby given of the following meeting: Name: Advisory Committee on Heritable Disorders in Newborns and Children. Dates and Times: May 9, 2016, 9:00 a.m. to 5:00 p.m. (Meeting time is VerDate Sep<11>2014 17:25 Mar 31, 2016 Jkt 238001 tentative.) May 10, 2016, 9:00 a.m. to 3:00 p.m. (Meeting time is tentative.) Place: Webcast and In-Person, Fishers Lane Conference Center, Terrace Level, 5635 Fishers Lane, Rockville, MD 20852. Status: The meeting will be open to the public with attendance limited to space availability. Participants also have the option of viewing the meeting via webcast. Whether attending in-person or via webcast, all participants must register for the meeting. The registration link will be made available at http:// www.hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders/. The registration deadline is Friday, April 29, 2016, 11:59 p.m. Eastern Time. Purpose: The Advisory Committee on Heritable Disorders in Newborns and Children (Committee), as authorized by Public Health Service Act, title XI, section 1111 (42 U.S.C. 300b–10), as amended by the Newborn Screening Saves Lives Reauthorization Act of 2014 (Pub. L. 113–240), was established to advise the Secretary of the Department of Health and Human Services about the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. In addition, the Committee’s recommendations regarding additional conditions/ heritable disorders for screening that have been adopted by the Secretary are PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 included in the Recommended Uniform Screening Panel (RUSP) and constitute part of the comprehensive guidelines supported by the Health Resources and Services Administration. Pursuant to section 2713 of the Public Health Service Act, codified at 42 U.S.C. 300gg–13, non-grandfathered health plans and group and individual health insurance issuers are required to cover evidence-informed care and screenings included in the HRSA-supported comprehensive guidelines without charging a co-payment, co-insurance, or deductible for plan years (in the individual market, policy years) beginning on or after the date that is 1 year from the Secretary’s adoption of the condition for screening. Agenda: The Committee will hear presentations and discussions on topics including newborn screening long-term follow-up, the Newborn Sequencing in Genomic Medicine and Public Health projects, screening for lysosomal storage disorders, and prenatal education regarding newborn screening bloodspots. The Committee will also review draft reports from the Pilot Study and Cost Analysis workgroups and hear updates from the Committee’s subcommittees on Laboratory Standards and Procedures, Follow-up and Treatment, and Education and Training Tentatively, the Committee is expected to review and/or vote on whether or not the nominated condition Guanidinoacetate Methyltransferase E:\FR\FM\01APN1.SGM 01APN1 asabaliauskas on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 63 / Friday, April 1, 2016 / Notices Deficiency should be referred for a full evidence-based review. This vote does not involve a proposed addition of a condition to the Recommended Uniform Screening Panel. The meeting agenda will be available two (2) days prior to the meeting on the Committee’s Web site: http://www.hrsa.gov/ advisorycommittees/mchbadvisory/ heritabledisorders. Public Comments: Members of the public may present oral comments and/ or submit written comments. Comments are part of the official Committee record. The public comment period is tentatively scheduled for both days of the meeting. Advance registration is required to present oral comments and/ or submit written comments. Registration information will be on the Committee Web site at http:// www.hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders. The registration deadline for public comments is of Friday April 29, 2016, 11:59 p.m. (Eastern Time). Written comments must be received by the deadline of Friday April 29, 2016, 11:59 p.m. (Eastern Time) in order to be included in the May meeting briefing book. Written comments should identify the individual’s name, address, email, telephone number, professional or business affiliation, type of expertise (i.e., parent, researcher, clinician, public health, etc.), and the topic/subject matter of comments. To ensure that all individuals who have registered to make oral comments can be accommodated, the allocated time may be limited. Individuals who are associated with groups or have similar interests may be requested to combine their comments and present them through a single representative. No audiovisual presentations are permitted. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed below at least 10 days prior to the meeting. For additional information or questions on public comments, please contact Alaina Harris, Maternal and Child Health Bureau, Health Resources and Services Administration; phone: (301) 443–0721; or email: aharris@hrsa.gov. Contact Person: Anyone interested in obtaining other relevant information should contact Alaina Harris, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18W66, 5600 Fishers Lane, Rockville, Maryland 20857; phone: (301) 443–0721; or email: aharris@ hrsa.gov. More information on the Advisory Committee is available at http:// VerDate Sep<11>2014 17:25 Mar 31, 2016 Jkt 238001 www.hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2016–07321 Filed 3–31–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Temporary Reassignment of State, Tribal, and Local Personnel During a Public Health Emergency Office of the Secretary, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Department of Health and Human Services, Office of the Secretary is announcing the availability of a final guidance entitled ‘‘Guidance for Temporary Reassignment of State, Tribal, and Local Personnel during a Public Health Emergency.’’ Section 201 of the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), Public Law 113–5, amends section 319 of the Public Health Service (PHS) Act to allow the Secretary of HHS, when she declares a public health emergency under section 319 of the PHS Act, to authorize, upon request by a state or tribal organization or their designee, the temporary reassignment of state, tribal, and local personnel funded through programs authorized under the PHS Act to immediately address a public health emergency in the state or Indian tribe. This final guidance addresses that provision. ADDRESSES: Copy of the final guidance may be obtained at www.PHE.gov!femporacyReassignment. Additional Information: For additional information, please contact: Lisa Kaplowitz, MD, MSHA, Deputy Assistant Secretary, Office of Policy and Planning, Office of the Assistant Secretary for Preparedness and Response, 200 Independence SW., Washington, DC 20004, telephone number (202) 205–2882. SUPPLEMENTARY INFORMATION: Section 201 of PAHPRA, Public Law 113–5, amends section 319 of the PHS Act to allow the Secretary of HHS, when she declares a public health emergency under section 319 of the PHS Act, to authorize, upon request by a state or tribal organization or their designee, the temporary reassignment of state, tribal, and local personnel funded though programs authorized under the PHS Act to immediately address a public health emergency in the state or Indian tribe. SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 18865 The PHS Act requires that HHS issue proposed guidance on this provision, to be followed by a 60-day public comment period. Consistent with this requirement, a notice appeared in the Federal Register on October 1, 2013 (78 FR 60283) notifying the public that HHS was accepting comments on such proposed guidance. This 60-day public comment period concluded in December 2013. There were nine submissions received in the public comment period. Five of the submissions were local governments, one state government, and three associations. Revisions made based on feedback received included setting timelines for HHS to review; standardizing the request template for states and Indian tribes, expanding the post event reporting requirements from 90 to 120 days, and clarifications on which Public Health Service programs were potentially affected. The temporary reassignment provision is applicable to state, tribal, and local public health department or agency personnel whose positions are funded, in full or part, under PHS programs. This authority terminates on September 30, 2018. This new provision provides an important flexibility to state and local health departments and tribal organizations during an event requiring all the resources at their disposal. The temporary reassignment provision permits state, tribal, and local personnel to be voluntarily reassigned so they can immediately respond to the public health emergency in the affected jurisdiction. Dated: September 1, 2015. Sylvia Burwell, Secretary. Editorial Note: This document was received for publication by the Office of the Federal Register on March 29, 2016. [FR Doc. 2016–07404 Filed 3–31–16; 8:45 am] BILLING CODE 4150–37–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [Docket No. USCBP–2016–0016] Termination of the Advisory Committee on Commercial Operations to U.S. Customs and Border Protection; Establishment of the Commercial Customs Operations Advisory Committee U.S. Customs and Border Protection, Department of Homeland Security. AGENCY: E:\FR\FM\01APN1.SGM 01APN1

Agencies

[Federal Register Volume 81, Number 63 (Friday, April 1, 2016)]
[Notices]
[Pages 18864-18865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07321]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders in Newborns and 
Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App.), notice is 
hereby given of the following meeting:
    Name: Advisory Committee on Heritable Disorders in Newborns and 
Children.
    Dates and Times: May 9, 2016, 9:00 a.m. to 5:00 p.m. (Meeting time 
is tentative.) May 10, 2016, 9:00 a.m. to 3:00 p.m. (Meeting time is 
tentative.)
    Place: Webcast and In-Person, Fishers Lane Conference Center, 
Terrace Level, 5635 Fishers Lane, Rockville, MD 20852.
    Status: The meeting will be open to the public with attendance 
limited to space availability. Participants also have the option of 
viewing the meeting via webcast. Whether attending in-person or via 
webcast, all participants must register for the meeting. The 
registration link will be made available at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/. The registration 
deadline is Friday, April 29, 2016, 11:59 p.m. Eastern Time.
    Purpose: The Advisory Committee on Heritable Disorders in Newborns 
and Children (Committee), as authorized by Public Health Service Act, 
title XI, section 1111 (42 U.S.C. 300b-10), as amended by the Newborn 
Screening Saves Lives Reauthorization Act of 2014 (Pub. L. 113-240), 
was established to advise the Secretary of the Department of Health and 
Human Services about the development of newborn screening activities, 
technologies, policies, guidelines, and programs for effectively 
reducing morbidity and mortality in newborns and children having, or at 
risk for, heritable disorders. In addition, the Committee's 
recommendations regarding additional conditions/heritable disorders for 
screening that have been adopted by the Secretary are included in the 
Recommended Uniform Screening Panel (RUSP) and constitute part of the 
comprehensive guidelines supported by the Health Resources and Services 
Administration. Pursuant to section 2713 of the Public Health Service 
Act, codified at 42 U.S.C. 300gg-13, non-grandfathered health plans and 
group and individual health insurance issuers are required to cover 
evidence-informed care and screenings included in the HRSA-supported 
comprehensive guidelines without charging a co-payment, co-insurance, 
or deductible for plan years (in the individual market, policy years) 
beginning on or after the date that is 1 year from the Secretary's 
adoption of the condition for screening.
    Agenda: The Committee will hear presentations and discussions on 
topics including newborn screening long-term follow-up, the Newborn 
Sequencing in Genomic Medicine and Public Health projects, screening 
for lysosomal storage disorders, and prenatal education regarding 
newborn screening bloodspots. The Committee will also review draft 
reports from the Pilot Study and Cost Analysis workgroups and hear 
updates from the Committee's subcommittees on Laboratory Standards and 
Procedures, Follow-up and Treatment, and Education and Training 
Tentatively, the Committee is expected to review and/or vote on whether 
or not the nominated condition Guanidinoacetate Methyltransferase

[[Page 18865]]

Deficiency should be referred for a full evidence-based review. This 
vote does not involve a proposed addition of a condition to the 
Recommended Uniform Screening Panel. The meeting agenda will be 
available two (2) days prior to the meeting on the Committee's Web 
site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
    Public Comments: Members of the public may present oral comments 
and/or submit written comments. Comments are part of the official 
Committee record. The public comment period is tentatively scheduled 
for both days of the meeting. Advance registration is required to 
present oral comments and/or submit written comments. Registration 
information will be on the Committee Web site at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders. The registration 
deadline for public comments is of Friday April 29, 2016, 11:59 p.m. 
(Eastern Time). Written comments must be received by the deadline of 
Friday April 29, 2016, 11:59 p.m. (Eastern Time) in order to be 
included in the May meeting briefing book. Written comments should 
identify the individual's name, address, email, telephone number, 
professional or business affiliation, type of expertise (i.e., parent, 
researcher, clinician, public health, etc.), and the topic/subject 
matter of comments. To ensure that all individuals who have registered 
to make oral comments can be accommodated, the allocated time may be 
limited. Individuals who are associated with groups or have similar 
interests may be requested to combine their comments and present them 
through a single representative. No audiovisual presentations are 
permitted. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the contact person listed below at least 
10 days prior to the meeting. For additional information or questions 
on public comments, please contact Alaina Harris, Maternal and Child 
Health Bureau, Health Resources and Services Administration; phone: 
(301) 443-0721; or email: aharris@hrsa.gov.
    Contact Person: Anyone interested in obtaining other relevant 
information should contact Alaina Harris, Maternal and Child Health 
Bureau, Health Resources and Services Administration, Room 18W66, 5600 
Fishers Lane, Rockville, Maryland 20857; phone: (301) 443-0721; or 
email: aharris@hrsa.gov.
    More information on the Advisory Committee is available at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-07321 Filed 3-31-16; 8:45 am]
BILLING CODE 4165-15-P